Post by
august202013 on Aug 08, 2024 3:01am
LONG TERM MINORITY SHAREHOLDERS DID NOT MAKE A MISTAKE !
MOST LONG TERM MINORITY SHAREHOLDERS DID NOT MAKE A MISTAKE FOR NOT SELLING @ 0.89 OR 0.75 IN 2020 BECAUSE MEDMIRA COVID-19 TEST KIT WORKS ! OBTAINED EUA FROM BIG BROTHER AND WAS SELLING IN US UNTIL CONNED INTO VOLUNTEERING TO WITHDRAW IT FOR A PROMISE TO BE ISSUED WITH A NEW EUA. ALSO OBTAINED CE MARK FOR SALE IN EUROPE WAS SELLING TILL COVID-19 TAILEND.
THEREFORE MEDMIRA COVID-19 TEST KIT BY HC WORKS !
QUESTION 1. WHY BIG BROTHER SABOTAGE MEDMIRA ?
QUESTION 2. SHOULD MEDMIRA RECEIVE ANY COMPENSATION FROM BIG BROTHER?
QUESTION 3. OPPORTUNITY LOSS AROSE WHICH OTHERWISE COULD REPOSITION
MEDMIRA TO EXPEND INTO OTHER AREAS WITH WINDFALL FROM HC
COVID-19 TEST KIT AND MEDMIRA WOULD POISE FOR GROWTH. SIMILARLY
MOST OF MEDMIRA LONG TERM MINORITY SHAREHOLDERS WOULD HAVE
ALSO BE REWARDED.
QUESTION 4. WHY DID'NT HC ISSUE MEDMIRA ANY APPROVAL WHEN MEDMIRA IS A
CANADIAN COMPANY AND THEIR COVID-19 TEST KIT WORKS EVIDENT
BIG BROTHER 1ST EUA AND WAS ALREADY SELLING IN US UNTIL BEING
SABOTAGE AND WAS ISSUE CE MARK FOR SALE IN EUROPE TILL
COVID-TAIL END.
QUESTION 5. WHY DID'NT HC ISSUE ANY APPROVAL BUT COULD ISSUE SPARTAN
BIOSCIENCE WITH ONE IN JANUARY, 2021 ONLY TOSEE THEM FILE FOR
CREDITORS PROTECTION APRIL, 2021 FOR ISSUES WITH THEIR COVID-19
TEST KIT,
QUESTION 6. DOES MEDMIRA GET/DESERVE SOME KIND OF COMPENSATION.
QUESTION 7. THERE WAS ALSO ANOTHER CANADIAN COMPANY HC ISSUED APPROVAL
PURCHASED THEIR COVID-19 TEXT KIT BUT ALSO HAD ISSUES.
CONSEQUENTLY IT WAS REPORTED TO HAVE BEEN DISCARDED.
QUESTION 8. WHY THEN HC DID'NT BUY FROM MEDMIRA? WHEN MEDMIRA COVID-19
TEST KIT ALREADY PROOF WORKING AND MEDMIRA IS A CANADIA
COMPANY.
QUESTION 9. IS THERE SOMETHING WRONG WITH THE NAME MEDMIRA?
HOW AND WHY A WORKING COVID-19 TEST KIT THAT WORKS
WAS NOT CHOOSEN AND INSTEAD OPTED FOR SOMEOTHER THAT
DON'T? ISN'T THAT SABOTAGE? OR THERE IS ANOTHER TERM?